Beyond its primary role in diabetes treatment, SGLT-2 inhibitors have demonstrated versatility in various health aspects, offering benefits beyond glucose reduction.
Sabrina Bahadori, PharmD Candidate
Advertisement
Articles by Sabrina Bahadori, PharmD Candidate
Advertisement
Latest Updated Articles
Bexagliflozin (Brenzavvy): Advancing Diabetes Management With SGLT-2 InhibitionPublished: September 7th 2023 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Eli Lilly, Novo Nordisk Strike MFN Deals With Trump Administration to Lower GLP-1 Prices
2
Environmental Factors Could Influence Type 1 Diabetes Risk in Children Through Epigenetic Changes
3
Less Common Pneumococcal Serotypes Cause More Severe Community-Acquired Pneumonia
4
FDA Approves Daratumumab and Hyaluronidase-fihj for High-Risk Smoldering Multiple Myeloma
5
